{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:58:09Z","timestamp":1767981489806,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.virusres.2004.02.026","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T09:21:14Z","timestamp":1082971274000},"page":"139-145","source":"Crossref","is-referenced-by-count":32,"title":["Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers"],"prefix":"10.1016","volume":"103","author":[{"given":"I.A","family":"de Bruijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Nauta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Gerez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M","family":"Palache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2004.02.026_BIB1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(95)91434-X","article-title":"Reduction in mortality associated with influenza vaccine during 1989\u201390 epidemic","volume":"346","author":"Ahmed","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2004.02.026_BIB2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S0022172400064834","article-title":"Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using singel radial haemolysis","volume":"92","author":"Al-Khayatt","year":"1984","journal-title":"J. Hyg. Camb."},{"key":"10.1016\/j.virusres.2004.02.026_BIB3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(99)00404-1","article-title":"Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes [in process citation]","volume":"18","author":"Arkema","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2004.02.026_BIB4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archinte.159.2.182","article-title":"Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies","volume":"159","author":"Beyer","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.virusres.2004.02.026_BIB5","unstructured":"Beyer, W.E.P., 2002. Clinical Expert Report\u2013Virosomal Subunit Influenza Vaccine. In file Solvay Pharmaceuticals, 28 March."},{"key":"10.1016\/j.virusres.2004.02.026_BIB6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01586187","article-title":"Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies","volume":"15","author":"Beyer","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virusres.2004.02.026_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-199815010-00001","article-title":"Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. A review and meta-analysis of the literature","volume":"15","author":"Beyer","year":"1998","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.virusres.2004.02.026_BIB8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1020198908574","article-title":"Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs","volume":"22","author":"Bungener","year":"2002","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.virusres.2004.02.026_BIB9","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0264-410X(02)00103-2","article-title":"Virosome-mediated delivery of protein antigens to dendritic cells","volume":"20","author":"Bungener","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2004.02.026_BIB10","unstructured":"Committee for Proprietary Medicinal Products, 1997. Note for guidance on harmonization of requirements for influenza vaccines, CPMP\/BWP\/214\/96."},{"key":"10.1016\/j.virusres.2004.02.026_BIB11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0264-410X(96)00040-0","article-title":"A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans","volume":"14","author":"Cryz","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2004.02.026_BIB12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/pgmj.49.569.159","article-title":"Inactivated influenza vaccines. 2. Laboratory indices of protection","volume":"49","author":"Dowdle","year":"1973","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.virusres.2004.02.026_BIB13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02786466","article-title":"The immune system in the elderly: I. Specific humoral immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virusres.2004.02.026_BIB14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02786467","article-title":"The immune system in the elderly: II. Specific cellular immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virusres.2004.02.026_BIB15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-123-7-199510010-00008","article-title":"The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature","volume":"123","author":"Gross","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.virusres.2004.02.026_BIB16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AEM.18.5.824-833.1969","article-title":"Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation","volume":"18","author":"Hierholzer","year":"1969","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.virusres.2004.02.026_BIB17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0264-410X(96)00302-7","article-title":"Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness","volume":"15","author":"Hirota","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2004.02.026_BIB18","doi-asserted-by":"crossref","unstructured":"Monto, A.S., 1996. The clinical efficacy of influenza vaccination. Pharmacoeconomics (Suppl. 3) 16\u201325.","DOI":"10.2165\/00019053-199600093-00006"},{"key":"10.1016\/j.virusres.2004.02.026_BIB19","unstructured":"Monto, A.S., Ohmit, S.E., 1996. Effectiveness evaluation of inactivated influenza vaccines: methods and results. In: Brown, L.E., Hampson, A.W., Webster, R.G. (Eds.), Options for the Control of Influenza III. Proceedings of the Third International Conference on Options for the Control of Influenza, Cairns, Australia, 4\u20139 May 1996. Excerpta Medica, Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo, pp. 93\u201396."},{"key":"10.1016\/j.virusres.2004.02.026_BIB20","unstructured":"Nguyen-Van-Tam, J.S., Ahmed, A.H., Nicholson, K.G., Pearson, J.C.G., 1996. Reduction in hospital admissions for pneumonia, influenza, bronchitis and emphysema associated with influenza vaccine during the 1989\u201390 epidemic in Leicestershire, UK. In: Brown, L.E., Hampson, A.W., Webster, R.G. (Eds.), Options for the Control of Influenza III. Proceedings of the Third International Conference on Options for the Control of Influenza, Cairns, Australia, 4\u20139 May. Excerpta Medica, pp. 107\u2013112."},{"key":"10.1016\/j.virusres.2004.02.026_BIB21","unstructured":"Nichol, K.L., 1996. Clinical effectiveness of influenza vaccine in community-living seniors. In: Brown, L.E., Hampson, A.W., Webster, R.G. (Eds.), Options for the Control of Influenza III. Proceedings of the Third International Conference on Options for the Control of Influenza, Cairns, Australia, 4\u20139 May 1996. Excerpta Medica, Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo, pp. 119\u2013122."},{"key":"10.1016\/j.virusres.2004.02.026_BIB22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000213803","article-title":"Effectivenss of influenza vaccine in the elderly","volume":"42","author":"Nichol","year":"1996","journal-title":"Gerontology"},{"key":"10.1016\/j.virusres.2004.02.026_BIB23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0264-410X(93)90375-8","article-title":"Influenza vaccines the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature","volume":"11","author":"Palache","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2004.02.026_BIB24","unstructured":"Palmer, D.F., Dowdle, W.R., Coleman, M.T., Schild, G.C., Hemagglutination-inhibition test. In: Welfare, P.H.S. (Ed.), Advanced Laboratory Technicals for Immunological Diagnostic, U.S. Department Health, Atlanta pp. 25\u201362."},{"key":"10.1016\/j.virusres.2004.02.026_BIB25","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2004.02.026_BIB26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","article-title":"Determinants of immunity to influenza infection in man","volume":"35","author":"Potter","year":"1979","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.virusres.2004.02.026_BIB27","first-page":"38","article-title":"Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly","volume":"13","author":"Pregliasco","year":"2001","journal-title":"Aging (Milano.)"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020400125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020400125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:20:52Z","timestamp":1585768852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817020400125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S016817020400125X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2004.02.026","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}